Vaxcyte Inc (NASDAQ: PCVX) is 9.08% higher on its value in year-to-date trading and has touched a low of $58.10 and a high of $121.06 in the current 52-week trading range. The question becomes, what are the chances the stock will continue to grow shareholders’ wealth in the market. Here’s what analysts think will happen to its price in the coming time. The PCVX stock was last observed hovering at around $78.14 in the last trading session, with the day’s gains setting it 11.15%.
Currently trading at $89.29, the stock is 5.44% and -1.29% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 2.33 million and changing 14.27% at the moment leaves the stock 4.05% off its SMA200. PCVX registered 47.05% gain for a year compared to 6-month gain of 7.27%. The firm has a 50-day simple moving average (SMA 50) of $90.8006 and a 200-day simple moving average (SMA200) of $85.71275.
The stock witnessed a 1.62% loss in the last 1 month and extending the period to 3 months gives it a -21.06%, and is 2.29% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 6.04% over the week and 4.29% over the month.
Vaxcyte Inc (PCVX) has around 254 employees, a market worth around $11.13B and $0.00M in sales. Distance from 52-week low is 53.68% and -26.24% from its 52-week high. The company has generated returns on investments over the last 12 months (-14.77%).
The EPS is expected to grow by 5.63% this year
467.0 institutions hold shares in Vaxcyte Inc (PCVX), with institutional investors hold 112.61% of the company’s shares. The shares outstanding are 124.43M, and float is at 120.32M with Short Float at 11.90%. Institutions hold 112.05% of the Float.
The top institutional shareholder in the company is FMR LLC with over 16.17 million shares valued at $1.22 billion. The investor’s holdings represent 13.788 of the PCVX Shares outstanding. As of 2024-06-30, the second largest holder is BLACKROCK INC. with 9.94 million shares valued at $750.56 million to account for 8.477 of the shares outstanding. The other top investors are VANGUARD GROUP INC which holds 9.8 million shares representing 8.3552 and valued at over $739.77 million, while JANUS HENDERSON GROUP PLC holds 7.5637 of the shares totaling 8.87 million with a market value of $669.72 million.
Vaxcyte Inc (PCVX) Insider Activity
Vaxcyte Inc disclosed in a document filed with the SEC on Jan 06 ’25 that Eydelman Mikhail (SVP, GEN COUNSEL & CORP SEC) sold a total of 5,000 shares of the company’s common stock. The trade occurred on Jan 06 ’25 and was made at $85.58 per share for $0.43 million. Following the transaction, the insider now directly holds 28222.0 shares of the PCVX stock.
Still, SEC filings show that on Jan 06 ’25, Eydelman Mikhail (Officer) Proposed Sale 5,000 shares at an average price of $84.23 for $0.42 million. The insider now directly holds shares of Vaxcyte Inc (PCVX).
